IONS
Ionis Pharmaceuticals Inc
45.60$
+2.4%
vs. previous close
Closing price · As of: Sep 28, 2026
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2.9% | 7.4% | -32.3% | 33.9% | 100.5% | 30.8% | 4.9% | 3.8% | -46.7% | -39.0% | -71.0% | -28.5% | |
| 4.4% | 3.6% | 2.6% | 1.6% | 2.1% | 1.4% | 2.4% | 2.4% | 3.8% | 2.9% | 2.8% | 2.4% | |
| 14.7% | 20.9% | 20.8% | 16.7% | 21.9% | 13.1% | 31.6% | 14.9% | 17.1% | 13.4% | 18.5% | 14.2% | |
| 3.3% | 21.6% | 22.6% | 16.7% | -26.5% | 14.4% | 72.5% | 16.2% | 17.5% | – | – | – | |
| 2.4% | 7.3% | -43.7% | 8.5% | 83.3% | -15.0% | -10.1% | -14.0% | 1.3% | -9.8% | -29.7% | -5.4% | |
| 5.2% | 4.1% | 3.3% | 7.4% | 2.9% | 3.2% | 5.6% | 2.2% | 3.4% | 3.6% | 6.4% | 5.4% | |
| -38.7% | -21.2% | 16.3% | -69.7% | -155.0% | -3.7% | 37.7% | 24.0% | -44.7% | -27.2% | -19.0% | -29.4% | |
| 0.0% | 0.0% | 0.0% | 0.0% | – | 14.7% | – | 2.1% | 1.9% | – | – | – | |
| 10.8% | 8.8% | 3.6% | 49.2% | 79.4% | -3.1% | -12.4% | -2.1% | -1.9% | – | – | – | |
| 16.4% | -0.2% | -0.9% | 10.9% | 16.2% | -2.0% | 43.0% | 51.6% | -8.6% | 11.0% | -6.3% | 53.2% | |
| 27.8% | 8.7% | 3.3% | 44.6% | 79.4% | 8.9% | -81.8% | 30.3% | -9.4% | 81.8% | 67.8% | 71.6% | |
| -7.9% | -5.0% | -12.7% | 8.7% | 24.9% | 36.0% | -39.2% | 58.2% | -100.9% | 15.6% | -22.3% | 13.8% | |
| -2.3% | 3.3% | -35.7% | 26.5% | 97.6% | 27.6% | -0.7% | 1.6% | -50.1% | -42.6% | -77.5% | -33.9% |
Data as of: September 28, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.